Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon Allaire

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.
Clinics and Research in Hepatology and Gastroenterology|January 8, 2024
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survivalAmel Mejait, Charles Roux, Marine Soret, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2024
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-BevacizumabPhilippe Sultanik, Claudia Campani, Edouard Larrey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2022
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCCEdouard Larrey, Bertille Campion, Manon Evain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCCFrancisca-Dora Copil, Claudia Campani, Marie Lequoy, et al.
Journal of Gastroenterology and Hepatology|June 26, 2019
Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosisSamia Rekik, Manon Allaire, Annie Mumana, et al.
Journal of Hepatocellular Carcinoma|August 27, 2025
A Patient Charter to Improve Care for Hepatocellular CarcinomaYasmine Hassan, Achim Kautz, Cary James, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2020
Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the WestManon Allaire, Weam El Hajj, Ségolène Brichler, et al.
Medical Education Online|June 27, 2024
Clues for improvement of research in objective structured clinical examinationJean Philippe Foy, Laure Serresse, Maxens Decavèle, et al.
European Journal of Anaesthesiology|February 13, 2025
Current insights into anaesthesia and critical care management of patients with hepatocellular carcinoma: Multifaceted implications for the anaesthesiologist and intensive care physicianAntoine Monsel, Alexandre Sitbon, Charles Roux, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Clinics and Research in Hepatology and Gastroenterology|September 4, 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCCSayma Chaibi, Edouard Larrey, Jean Pierre Couty, et al.
Clinics and Research in Hepatology and Gastroenterology|January 8, 2024
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survivalAmel Mejait, Charles Roux, Marine Soret, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 28, 2024
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-BevacizumabPhilippe Sultanik, Claudia Campani, Edouard Larrey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2022
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCCEdouard Larrey, Bertille Campion, Manon Evain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCCFrancisca-Dora Copil, Claudia Campani, Marie Lequoy, et al.
Journal of Gastroenterology and Hepatology|June 26, 2019
Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosisSamia Rekik, Manon Allaire, Annie Mumana, et al.
Journal of Hepatocellular Carcinoma|August 27, 2025
A Patient Charter to Improve Care for Hepatocellular CarcinomaYasmine Hassan, Achim Kautz, Cary James, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2020
Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the WestManon Allaire, Weam El Hajj, Ségolène Brichler, et al.
Medical Education Online|June 27, 2024
Clues for improvement of research in objective structured clinical examinationJean Philippe Foy, Laure Serresse, Maxens Decavèle, et al.
European Journal of Anaesthesiology|February 13, 2025
Current insights into anaesthesia and critical care management of patients with hepatocellular carcinoma: Multifaceted implications for the anaesthesiologist and intensive care physicianAntoine Monsel, Alexandre Sitbon, Charles Roux, et al.
Pageof 9